24Indexed trials
mesh condition
Supranuclear Palsy, Progressive
Intelligence
Supranuclear Palsy, Progressive intelligence: 24 indexed trials, 8 recruiting studies, 23 sponsors across 9 countries.
8Recruiting
23Sponsors
9Countries
Leading sponsors
University of Colorado, Denver20 recruiting
Biogen10 recruiting
California Pacific Medical Center Research Institute10 recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico10 recruiting
Fujian Medical University Union Hospital10 recruiting
Huashan Hospital10 recruiting
IRCCS San Raffaele Roma10 recruiting
KineMed10 recruiting
Loma Linda University10 recruiting
MD Stem Cells11 recruiting
Molecular NeuroImaging10 recruiting
Oregon Health and Science University11 recruiting
Geographic activity
United States13trials
China3trials
Italy3trials
Germany1trials
Austria1trials
Sweden1trials
United Arab Emirates1trials
United Kingdom1trials
Belgium1trials
Leading interventions
BIIB0921trials
CUE1 non-invasive device1trials
CUE1+ device active vs sham CUE1+ device1trials
CoMDA associated with Neural Net 91 classificator1trials
Complex eye movement exam1trials
DaTscan1trials
Droxidopa1trials
Elecsys (Roche) Abeta42, Ttau and Ptau1trials
Flutemetamol F18 Injection1trials
Home Visit Program1trials
Intravenous and Intranasal BMSC1trials
3T MRI imaging of the brain1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.